Read + Share
Amedeo Smart
Independent Medical Education
Stringer-Reasor EM, May JE, Olariu E, Caterinicchia V, et al. An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer. Breast Cancer Res 2021;23:30.PMID: 33663560
Email
LinkedIn
Facebook
Twitter
Privacy Policy